Clin2
NCT06971445Likely a fitEnrolling by invitation

Omega-3 supplements for pregnant women with HIV

Pregnant HIV Positive Women

Part of Immune system & allergy, Infections clinical trials.

This trial tests whether taking omega-3 supplements can improve pregnancy outcomes and reduce inflammation in pregnant women living with HIV who are on antiretroviral therapy. If you are between 20 and 29 weeks pregnant with a single baby, you may be eligible to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
92 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are currently pregnant with one baby.
  • You are between 20 and 29 weeks pregnant (counting from the first day of your last period).
  • You are living with HIV and taking antiretroviral therapy.
  • You agree to take an omega-3 supplement daily as part of the study.
  • You do not have gestational diabetes or preeclampsia at the start.
  • You do not smoke or use drugs currently, and you are not allergic to fish.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07664423Not yet recruiting
HIV doula support for pregnant and new mothers

This study offers a doula program to help pregnant women and new mothers living with HIV. It aims to improve health and well-being for both mother and baby.

Miami, Florida
NCT06666530Recruiting
Quality of life for pregnant women with HIV

This study looks at how being pregnant while living with HIV affects your quality of life and the care you receive. It aims to understand your experiences and needs during this time.

Paris
NCT00825929Recruiting
Drug levels in HIV treatment during pregnancy

This study measures how HIV medicines move through your body during pregnancy by collecting blood samples after you take your regular treatment. It may help improve understanding of dosing and drug levels in pregnant people living with HIV.

Brussels
NCT07637942Not yet recruiting
HIV Treatment During Pregnancy With Long-Acting Injections

This study looks at whether two HIV medicines given as injections every 4 weeks—cabotegravir and rilpivirine—are safe and effective for pregnant women with HIV who have an undetectable viral load. The goal is to help pregnant people with HIV stay healthy and reduce the risk of passing HIV to their baby.

La Jolla, California
NCT07271758Enrolling by invitation
Omega-3 blood screening in early pregnancy

This study tests if checking DHA (a key omega-3 fatty acid) levels early in pregnancy helps you and your baby. You may get results and guidance to improve your diet.

Winston-Salem, North Carolina
NCT07761819Not yet recruiting
Olive oil for heart health in people living with HIV

This study tests whether adding extra virgin olive oil to your diet can help prevent heart attacks, strokes, or other heart problems in people living with HIV. If you join, you'll be asked to follow a Mediterranean-style diet and take olive oil daily.

Marbella, Málaga

Hear when a new Pregnant HIV Positive Women trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.